ILF2 and Miyoshi myopathy: To evaluate whether MM cells could eventually become resistant to the DNA damage induced by ILF2 depletion, we treated JJN3, KMS11, MM1R, H929, and RPMI-8226 cells with NT or ILF2 ASOs for more than 3 weeks.